Repeat antivenom administration following crotalidae immune F(ab’)2 antivenom in Agkistrodon species: a case series
AbstractCrotalidae immune F(ab’)2 [equine] was approved for the treatment of North American rattlesnake envenomation in 2015 and Agkistrodon envenomation in 2021 after a phase 3 trial demonstrated lower rates of late hemotoxicity compared to crotalidae polyvalent immune fab-ovine (Fab) in a populati...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Toxicology Communications |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/24734306.2023.2280893 |